Sunfengxia From Clinical Studies Of Treating Bronchial Asthma

In this paper,This article from the two aspects of theory and clinical research professo sun feng xia from phlegm and blood stasis syndrome differentiation bronchial asthma a systematic in-depth research. Paper is divided into four parts, bronchial asthma clinical research progress in the first part, a review of the Treatment from phlegm and blood. The second part summarizes the Sun Fengxia academic thought and academic experience treating bronchial asthma. The third part, to Professor Sun Fengxia Treating Bronchial Asthma from Phlegm academic point of view as a guide, the application of lungs and kidney, clinical research remission Huatanquyu law treatment of bronchial asthma.Objective:to observe the gas-solid table according to interest, lung and benefiting kidney and phlegm and dispelling stasis method and development of xiao blood soup combined inhaled nimesulide overlapping treatment of bronchial asthma remission of clinical curative effect and mechanism of action.Methods: according to the plan, in this study, a total of 60 patients, randomly divided into 2 groups, treatment group 30 cases and control group 30 people, Treatment group using internal and a dose of daily check xiao blood soup, each about 250 ml tisanes, daily oral once in the morning and night, taking in March, (such as asthma acute attack, a cold, diarrhea is temporarily withdrawn). Plus salmeterol/assigned powder inhalant (nimesulide overlapping) (British GSK production,50/250 ug), each time 1,2 times a day; For three months in a row; After 3 months all sucked into 11 times a day (such as asthma acute attack, no reduction). Control group:XiFu salmeterol/assigned powder inhalant (nimesulide overlapping) (British GSK production,50/250 ug), each time 1,2 times a day; For three months in a row; After 3 months all sucked into 11 times a day (such as asthma acute attack, no reduction).Results:? treatment group and the control group, the total effective rate were 93.3%, 80.0%, of which 11 cases of treatment group, clinical cure, effective in 17 cases,2 cases; control group, eight cases of clinical cure, effective in 15 cases,7 cases, the treatment group There was significant difference compared with the control group (P <0.05).,? observe clinical symptom scores before and after treatment, the treatment group and the control group before and after treatment symptom scores compared to the situation there was a significant difference (P<0.01), indicating the treatment effect is significant, the treatment group than the control group.? functional testing, the two groups after treatment were significantly improved lung function in patients with FEV1, FVC, FEF, and treatment Before there were significant differences (P<0.05). The results suggest that this treatment effect in patients with a significant improvement in lung capacity. Leech, with blood Po Yu, through the meridians effect,? observation average colds, asthma often compare the two groups after treatment, the results showed that the treatment group and the control group, the average common cold, asthma frequency difference was statistically significant (P<0.05). The treatment group can prolong remission, reduce colds, asthma onset times. Findings from the study of asthma severity, the treatment group was significantly lighter than the control group.? treatment group after treatment of peripheral blood eosinophils significantly decreased peripheral blood eosinophils decreased from 0.653±0.26 before treatment to 0.33 after treatment0.23 soil, there are significant differences by the statistical test (p<0.05), the method described in this study can significantly reduce the content of eosinophils in peripheral blood cells. The peripheral blood eosinophil decline the prompt chronic airway inflammation airway allergens improved.? treatment group after treatment decreased serum immunoglobulin IgE, and IgA, IgM, IgG is significantly higher, statistically significant difference test (p<0.01), described in this study may also regulate immune function, enhance the body disease resistance.The subject method of treatment using the clinical efficacy safe and reliable, no significant side effects, worthy of clinical application. Conclusion:Phlegm related theory, preclude the use of ZhiXiao Huayu decoction for treatment of bronchial asthma in remission with good effect.The four part, a brief summary of the full text.